Anchorage / Pat McGrath interview prep — Maxwell Nides A decision-frame supplement to the comprehensive prep doc. The existing doc tells you what the deals were. This one tells you what you would have done at each fork in time, applying Pat's frameworks deal-by-deal, with the Talen-style hidden-value question stress-tested against each name. Trifecta-reviewed.
Market marks as of 2026-05-25 vs. the estimates in the rest of this doc:
| Deal | Tranche | Doc estimate | Market 2026-05-25 | Read |
|---|---|---|---|---|
| Newfold | $100M new-money 1L | ~98 (par-equiv) | 67 | DIVERGED — credit re-rated to deep distress |
| Newfold | Amended TLB 2L | 82-90 | 66 | DIVERGED — old fulcrum entry zone gone |
| Newfold | Exchanged 11.75 3L | 65-75 | 30 | DIVERGED — confirms market is pricing accelerated default |
| Tropicana | FL1O $400M | 92-96 | par | Confirms (yield trade, AHC holding) |
| Tropicana | FL2O $1.42B | 65-75 | 70 | Confirms entry zone (toehold at 70 = the trade) |
| Tropicana | FLTO $750M | 35-50 | 35 | Confirms AVOID call (floor of estimate) |
Two implications for the pitch:
Tropicana thesis is reinforced. Prices haven't moved against the doc's planned entry. FL2O at 70 is precisely the 65-70 toehold zone the prep doc identified. The DIP-staging trade is still on, with no slippage in entry economics. Build the 5-8% FL2O toehold at 70 → cash deployed $50-80M for $71-114M of notional → pre-commit DIP backstop for 2027.
Newfold thesis flipped. The TLB 2L at 82-85 "credit trade with free AI optionality" is dead — the 2L is at 66, the asymmetry inverted, and the third-out at 30 confirms the market is pricing imminent re-stress. The new pitch is the new-money 1L at 67 as pre-petition DIP-equivalent positioning: top-of-waterfall priority, SOFR+575 floating coupon (~15-16% current yield), near-certain par recovery in Ch11 (1L recovers 100% on any TEV > $100M), and the natural DIP-bidder seat if Clearlake/Siris re-stress. Caveat: the 1L's ~1pt premium to the 2L screams technical / re-priming risk — diligence test before sizing is whether $30-50M can clear near 70¢, and whether the ICA grants full-collateral priority or a carve-out. If the AHC isn't selling, the real clearing level is probably 78-82.
Drop "free Talen-style optionality" framing for Newfold entirely. Replace with: "deep-distressed credit with embedded execution optionality that becomes more valuable in a Ch11 reorg, captured through the senior tranche, not the impaired one."
Cabinetworks unchanged — no new marks; thesis (FTC-conditioned 2L at 72-78) stands.
"Do they actually have a severable business or assets that they can pull away from the collateral group? Are there lenders that are willing to underwrite that? Do the docs allow for it? Are there holes in the documents that actually allow very clearly for them to put that much of an asset into an unrestricted subsidiary? And then you can back into how much money they can actually raise on that, and then you can kind of price it."
"The LMEs that we participate in, we're not going to do it to kind of play the LME or a structural outcome. Elevating up in a capital structure is good, but if we can't underwrite to the recovery of the business, at least through that security, then I'd be highly circumspect of like getting into that type of investment."
This is the gate. Every trade through Pat's desk passes the business-recovery test first, the structural-priority test second. Not the other way around.
Talen Energy filed Chapter 11 May 2022 as a stressed commodity merchant power name. The market priced the cap stack on commodity exposure + leverage. What it missed: the Susquehanna nuclear plant as a behind-the-meter power source for hyperscale data centers in the GW-demand AI era.
The Talen Test for each name in three questions: 1. What does the market price the business as today? (cycle / category / leverage) 2. What latent optionality on the asset base is nobody underwriting? (hidden capability, latent customer, structural shift) 3. Does my entry instrument own that optionality, or am I just clipping coupons while someone else captures it?
The third question is the Pat-framework gate. Talen worked for the unsec because they ended up holding the equity. If they'd been holders of a takeback term loan, the data-center upside would have repaid them at par and the equity captured the $18B AWS revenue stream. Owning the right instrument is half the trade.
Clearlake/Siris hosting + domain registrar roll-up: Bluehost, HostGator, Network Solutions, Web.com, Yoast. ~$1.1B revenue. EBITDA not publicly disclosed; underwrites to $200-280M stressed / $280-340M normalized. Dec 2025 LME closed: $100M new money + tiered exchange to 2029 + closed Akin co-op + side-pact NDAs + ~90% participation. Old 11.75% Notes → exchanged into a third-out secured tranche. 6% unsecured 2029 largely untouched.
T-18mo (mid-2024, Moody's still B3, revolver Feb 2026 catalyst visible)
Observable: 11.75% Notes in the low-50s [secondary reporting], pre-LME TLB in low-70s [unverified], 6% unsec ~20-30s. ABL maturity Feb 2026 is the structural clock.
T-12mo (late 2024, Akin signs the AHC co-op, closed to new entrants)
The co-op closing is the gating event. You're either in or you're not.
At LME (Dec 9, 2025)
Term sheet: $100M new money 2029 first-out (SOFR+575) + amend-and-extend on TLB + 11.75 Notes exchanged to third-out + side-pact NDAs + ~90% participation.
T+3mo (March 2026, post-LME secondary) — original framing, SUPERSEDED by 2026-05-25 marks
⚠️ The table below reflects the March 2026 entry-point thesis. Current market marks (2026-05-25) have materially diverged on Newfold — see refreshed table below and the PRICE REFRESH NOTE following the original framing. The thesis flipped from "TLB 2L at 82-85" to "NM 1L at 67."
New paper is trading. Stack: $100M first-out 2029 / amended TLB 2029 second-out / exchanged 11.75 third-out / old stubs / untouched 6% unsec 2029.
This was the clean-post-LME entry point as the doc penciled it. Pat's framework still applies; the entry tranche has changed.
| Tranche | March 2026 mark (est) | 2026-05-25 mark | Decision (refreshed) |
|---|---|---|---|
| New money 2029 first-out (~SOFR+575, ~10% all-in) | par-equiv (98-100) | 67 | ENTER — the new trade (top-of-waterfall + DIP-option seat at deep distressed entry) |
| Amended TLB 2029 second-out | 82-90 (was "Enter at 82-85") | 66 | PASS (asymmetry inverted; mid-case fair value, not entry zone) |
| Exchanged 11.75 third-out | 65-75 ("avoid") | 30 | AVOID (confirms wipe-in-bear thesis) |
| 6% unsec 2029 (untouched) | 25-35 | 25-35 (est) | Pass |
The base trade as of 2026-05-25 is the NM 1L at 67. Recovery floor near par (1L recovers 100¢ on any TEV > $100M). Current yield ~15-16% on SOFR+575 floating. Sole gating concern: the 1pt premium to the 2L is too tight for waterfall math — diligence test on clearing size + ICA scope determines sizing. The original 82-85 2L thesis is dead at these prices.
Hypothetical Ch11 (late 2026 / 2027) — the DIP-to-equity path
Per the existing prep doc: $300M DIP → 5x MOIC on cash deployment, 70-85% IRR. The pre-condition is being the largest pre-petition 1L holder. At the 2026-05-25 marks, that means owning the NM 1L at 67 (the natural pre-petition senior seat), not the TLB 2L at 66 (impaired fulcrum). The DIP-to-equity option now reaches through the senior tranche.
What the market prices: commoditized SMB hosting + domain registrar in secular decline; participated in an LME that bought 36 months and ~$2B of secured debt against ~$250M EBITDA. Roe-Rotaru double-default candidate.
What is the market missing?
Newfold publicly launched GatorClaw in 2026 (Bluehost brand) — a no-code visual platform to build, deploy, and run autonomous AI agents on Bluehost VPS infrastructure. Simultaneously, all Bluehost customers are being migrated to Oracle Cloud Infrastructure in 2026, optimizing every layer for "compute orchestration, storage, networking, and AI inference."
If you squint, this is the Talen pattern: - Legacy commoditized asset base (hosting infra = power generation) - Non-consensus future buyer (SMB AI agent deployment = hyperscale AI demand) - The cap-ex / asset is already in place — what's needed is a customer + a productization layer - The market still trades Newfold as melting-ice-cube hosting
Why this is a legitimate Talen-style thesis: - ~4.4M+ SMB customers on Bluehost/HostGator → real distribution channel for AI agent tools - The pricing model ($5-15/mo hosting + agent execution overage) has higher LTV than pure hosting - VPS hosting on OCI with always-on agent execution is genuinely the "SMB Vercel for AI agents" positioning - Comparable shape: Cloudflare Workers / Vercel trade at 15-25x revenue. Even partial credit to that positioning rerates the equity multiple
Why it might be a head-fake: - This is announced and on track. It's not non-consensus to management; pricing-in is happening in real time - SMBs adopt AI agents slowly. GoDaddy/Squarespace/Wix have larger distribution + faster product cycles - The Talen story worked because the asset was scarce (1,920MW of carbon-free baseload nuclear is irreplaceable). VPS infra is commoditized — agent hosting is available on AWS / Vercel / Fly.io / Cloudflare - Constant Contact remains structurally separated from Newfold (per the 2021 spin-out). Even if Clearlake/Siris monetize CC successfully, the LP-narrative value capture is outside Newfold's cap structure - Bluehost's brand permission to win AI-builder mindshare vs. Vercel/Cloudflare is weak
Pat's framework check (investment-first principle) — refreshed for 2026-05-25 marks: - Can you underwrite the business through your security? Yes on the NM 1L at 67 — recovery floor is near par on any TEV > $100M; the senior tranche captures the business through priority, not through the 2L's fulcrum exposure. The original framing of "yes on the TLB 2L at 82-85" no longer applies — at 66, the 2L is mid-case fair value, not asymmetric entry. - Can you justify reaching for the AI optionality through the more junior tranches (2L at 66, 3L at 30)? No. The 2L recovery is 47-87% across bear/base — you're paying for paper that pays out near where it trades. The 3L at 30 wipes in bear. Both fail the recovery-through-security test at refreshed prices.
The Talen-analogy framing is DEAD at refreshed prices.
The original doc framed the trade as "credit trade with embedded AI optionality worth 5-10 points above credit-only value." That framing assumed the 2L at 82-85 entry. At 2026-05-25 prices, the market is no longer paying for GatorClaw/OCI as upside — it's pricing accelerated default. The NM 1L at 67 + 2L at 66 + 3L at 30 is a deep-distressed cap-stack mark, not a slow-melt-hosting-with-AI-optionality mark.
Why Talen was the wrong analogy in any case: Talen worked because Susquehanna nuclear baseload is physically irreplaceable — AWS literally could not buy that 1,920MW of carbon-free behind-the-meter capacity anywhere else on that timeline. Bluehost VPS is the opposite — commoditized infra competing with Vercel, Cloudflare Workers, Fly.io, AWS Lightsail, plus GoDaddy/Squarespace/Wix have stronger SMB AI-builder distribution.
The correct framing at 2026-05-25 marks — senior-secured credit with embedded DIP option: - Buy the NM 1L at 67 as a deep-distressed senior-secured credit trade with near-par recovery floor - GatorClaw + OCI migration is execution optionality on management's AI roadmap — at 67 the market isn't paying for it. Don't pitch it as the trade thesis; pitch it as upside that doesn't underwrite the position. - The trade thesis is: top-of-waterfall priority + 15-16% current yield + DIP-bidder seat if Clearlake/Siris re-stress in 2027. That's the Anchorage pattern (J.Crew / At Home shape, reached through the senior tranche).
The Pat-style probe to preempt: "If the NM 1L is so attractive at 67, why is it only 1 point above the 2L? Either the priority is real or it isn't." The honest answer: the spread should be 15-25 points wide on waterfall math; the compression is pricing some combination of (a) thin AHC float producing a soft technical print, (b) re-priming risk if Clearlake runs another LME in 2027, (c) ICA carve-out / collateral scope gaps. The diligence answer determines size, not the trade. If the 67 is real for $30-50M of paper, it's a generational entry. If the clearing level is 78-82, it's still attractive but the headline-trade framing dilutes.
| Tranche | Pre-LME (mid-2024) | Pre-LME (stress, late-2025) | Post-LME doc est. | Market 2026-05-25 | Your entry zone |
|---|---|---|---|---|---|
| Revolver | 95 | 80 | par | par | n/a |
| Pre-LME TLB ($2.3B) | 75 | 60 | n/a (exchanged) | n/a | n/a |
| 11.75% Notes ($515M) | 55 | 45 | n/a (exchanged) | n/a | n/a |
| 6% Unsec ($500M) | 30 | 20 | 25-35 | 25-35 (est) | pass |
| New $100M 1L 2029 (NM) | n/a | n/a | ~98 | 67 | target 67-72 (was "pass") |
| Amended TLB 2L 2029 | n/a | n/a | 82-90 (target 82-85) | 66 | pass at 66 (was "target 82-85") |
| Exchanged 11.75 3L | n/a | n/a | 65-75 | 30 | avoid |
The TLB 2L is no longer the trade. At 66¢ the asymmetry that justified the 82-85 entry has inverted. Recovery math on $200-280M stressed EBITDA × 4-5x = $800M-$1.4B TEV minus $100M NM 1L paid at par leaves $700M-$1.3B for the $1.5B TLB = 47-87% recovery. At 66 you're paying mid-case fair value, not buying asymmetric upside. Bear-case loss is now ~25-30 points to mid-30s recovery (vs. the original 10-15 estimate).
The new-money 1L at 67 is the new trade. Three reasons: 1. Recovery floor near par. $100M of 1L recovers 100¢ in every Ch11 scenario where TEV > $100M. On a $1.1B-revenue domains + hosting business with sticky ARR, that floor is near-certain. Loss capped low single digits in a hard reorg. 2. DIP-bidder standing without a Ch11. Owning a meaningful slug of the 1L is the natural path to backstopping a future DIP — the J.Crew / At Home shape, reached through the senior tranche instead of an impaired fulcrum. 3. Current yield ~15-16% / YTM ~20%+ at 67 on SOFR+575 floating paper. The credit-book companion economics actually improved vs. the original 2L thesis.
But the 1L's ~1pt premium to the 2L is the diligence anomaly. The waterfall math says the priority premium should be 15-25 points wide. It isn't. Three reasons compress it: - Thin float, sticky AHC. $100M tranche held by Akin AHC; the 67 print may be 1-2 trades not the clearing level for size. - Re-priming risk. Holders of the original 11.75% notes watched their paper become today's 3L at 30. The market is pricing the NM 1L as "next to be primed if Clearlake/Siris run another LME in 2027." Re-priming converts today's 1L to tomorrow's 1.5L sitting on the same waterfall as the existing 2L. - ICA scope. "First-out" is contractual via Intercreditor — if priority is on a collateral carve-out (e.g., new IP, GatorClaw IP) rather than the full pool, the recovery cap is lower than $100M and the priority premium compresses.
Diligence test before sizing: 1. Call the desk — what size traded at 67, who's on the bid. If $1-2M one-dealer, real mark is 78-82 and the trade-of-the-year framing falls back to "attractive yield." If $20M+ multi-dealer, the 67 is real and asymmetry is genuine. 2. Read the ICA — is 1L priority over the full collateral pool or a carve-out, payment vs. lien, what triggers enforcement, what voting rights vs. 2L on enforcement. 3. Confirm Akin AHC holders aren't quietly defecting (if they are, that's the tell that they think the next LME is coming).
The pitch frame:
"Newfold price action since the December 2025 LME has materially diverged from where the doc penciled the post-LME entry. The 2L at 66 used to be the trade at 82-85 — that asymmetry is gone. The new trade is the new-money 1L at 67. Top-of-waterfall, near-certain par recovery, 15-16% current yield, and the natural DIP-bidder seat if Clearlake/Siris re-stress in 2027. The diligence anomaly is the 1pt premium to the 2L — the priority math says it should be 15-25pts wide. That's either a technical print I can exploit or a real signal about re-priming risk in the ICA, and the diligence answer determines size. Either way, this is now a senior-secured credit trade with embedded DIP-option upside, not the AI-optionality thesis the LME-close marks pointed to. GatorClaw and the OCI migration are execution items management still has to deliver; at 67 the market isn't paying for them, and I don't think we should either."
Data gaps: - What broke Dec-2025 to May-2026 — Q1 EBITDA print, domain renewal trend, GatorClaw launch metric, Clearlake equity walk? - Clearing level for $30-50M of NM 1L paper (the test that determines if the 67 is real) - ICA full text — collateral scope of 1L priority, ROFR on additional senior debt, voting/enforcement rights - Has the Akin AHC reformed around the NM tranche or dispersed? - CDS / option-implied default probs vs. cash prices
Original data gaps (still open): - True mid-2024 trading level of original 11.75% Notes (TRACE or LSTA fix) - Did Anchorage in fact participate in the Akin AHC? - Where did Clearlake/Siris's ~$100M new equity actually price (warrant strike, dilution waterfall)?
Largest private US cabinet manufacturer. Platinum Equity-owned since May 2021; AIP exited. ~$2B revenue. Brand portfolio across the price ladder: KraftMaid (flagship semi-custom dealer + Home Depot), Merillat (value/entry), Schuler (Home Depot exclusive), Quality Cabinets (multifamily/builder), Yorktowne, Medallion, Cardell. 19 facilities, ~8,000 employees post-2024 closures. May 2026 LME closed: TLB → senior secured second-out due Nov 2031, unsec notes → senior secured third-out due 2032, $100M new money first-out. 99% TLB / 96% notes participation.
T-18mo (late 2024, unsec notes printed at 48-49¢ in Aug 2024 secondary; ABL May 2026 catalyst visible)
Observable: TLB likely 70-80; unsec notes at the 48-49 Aug 2024 print level. Housing R&R is in the cyclical trough.
T-12mo (mid-2025, advisor retention public)
Public: Milbank/Houlihan for company, Paul Weiss/Evercore for TL ad hoc, Davis Polk/Rothschild for noteholder ad hoc, Cahill for ABL.
At LME (May 8, 2026)
Term sheet: $100M new money first-out (out to 2031), TLB → senior secured second-out (Nov 2031), notes → senior secured third-out (2032). 99% TLB / 96% notes participation. Cashless on the notes side.
T+3mo (Aug 2026, post-LME secondary)
New paper is trading. Stack: $100M first-out 2031 / TLB second-out Nov 2031 / new notes third-out 2032 / 2L term loan unchanged / Platinum equity.
| Tranche | Est. mark | Decision |
|---|---|---|
| New money first-out (~SOFR+650-700) | par-equiv (~98) | Pass — yield trade |
| TLB second-out Nov 2031 (fulcrum in housing-weak + MBC/AMWD closes) | 75-82 | Enter at 72-78 if conviction on FTC-block + housing 2027-2028 |
| New notes third-out 2032 (wipes in bear) | 55-65 | Avoid for base; tactical contrarian only |
| 2L term loan ($450M, unchanged) | 20-30 | Pass |
Hypothetical Ch11 (2028-2029, post-second maturity stress)
10x leverage on stressed EBITDA → unsustainable. DIP-to-equity setup: $200M DIP, ~$700M-1.0B TEV at 4-5x stressed EBITDA $150M. Implied DIP-to-equity captures ~50-60% of MBC public-market multiple — weak compared to At Home or J.Crew where the multiple at emergence is closer to public comp. The LME foreclosed the cleanest version of the playbook.
Angle 1: The FTC outcome on MBC/AMWD merger (the binary — but framed correctly)
The directional read — and this is where earlier framings of this trade got it backwards:
This is not a Talen-style hidden-value angle. It's a regulatory binary where the market's probabilities are knowable and the integration-distraction window is the real near-term tailwind for Cabinetworks, not the merger-blocked outcome.
Trade implication: the second-out at 72-78 is interesting if you believe the integration-distraction window is mispriced (the modal outcome), not if you believe FTC blocks. The clearance scenario is the underpriced path, not the block. Sit on it through FTC decision (likely Q3-Q4 2026) and the first 6-12 months of integration if it clears.
Angle 2: Industrial real estate of 19 facilities (structural)
Angle 3: Multifamily / builder channel — Quality Cabinets (structural)
Pat-framework synthesis: Cabinetworks has more Talen-style optionality than Newfold (FTC binary + RE collateral + builder pivot) but the underlying credit is more cyclical and the LME has structurally foreclosed the DIP-to-equity path. The right move is the second-out at 72-78 as a credit trade sized to your conviction on the FTC outcome — not a third-out punt.
| Tranche | Pre-LME (Aug 2024) | Pre-LME (early 2026) | Post-LME (May 2026, est) | Your entry zone |
|---|---|---|---|---|
| Pre-LME TLB | 70-80 | 55-65 | n/a (exchanged) | n/a |
| Pre-LME unsec notes | 48-49 (Aug 2024 print) | 40-50 | n/a (exchanged) | n/a |
| New $100M first-out 2031 | n/a | n/a | ~98 | pass |
| TLB second-out Nov 2031 | n/a | n/a | 75-82 | 72-78 (target) |
| New notes third-out 2032 | n/a | n/a | 55-65 | tactical only |
| 2L term loan (~$450M) | 20-30 | 20-30 | 20-30 | pass |
Data gaps: - Actual post-LME marks on second-out and third-out (May-Aug 2026 close + secondary) - Where did the unsec notes trade June-July 2024 pre-stress? Where did they trade Q1 2026 pre-term-sheet? - Has Anchorage taken any position? - Real estate appraisal range — does the IM include a propco optionality discussion? - Did Platinum contribute new equity in the May 2026 LME, or did the lenders fund the $100M alone?
PAI Partners juice carve-out from PepsiCo (Jan 2022, $3.3B EV; PepsiCo retained 39% + exclusive US DSD distribution). Brand portfolio: Tropicana (core OJ), Naked Juice (cold-press), KeVita (probiotic), Izze (sparkling), Dole licensed, Copella (UK), Punica (EU). ~$2.8B funded debt. May 2025 LME closed: $400M new money + 21pp in-/out-group differential (91¢ in / 70¢ out) + transfer restriction. The most aggressive intra-class differential of the cycle.
T-18mo (late 2023 / early 2024, FCOJ futures $4+, OJ volume in 5-year decline)
Private credit — no observable TRACE prices. Loan secondary in the LSTA system (LSTA tape access required to mark).
T-12mo (mid-2024, ongoing FCOJ spike, no formal stress signals yet)
Same position size. Watching for advisor retention, sponsor cash, or AHC formation.
T-3mo (Feb-Mar 2025, PAI bridge + PepsiCo $135M write-down + CNN/Debtwire bankruptcy story)
This is the moment the structural premium gets engineered. Carlyle/Fidelity/CVC organized in ~60 days from bridge to term sheet.
At LME (May 13, 2025)
Term sheet: $400M new money + 91¢ in / 70¢ out + transfer restriction + near-unanimous participation.
T+6mo (Nov 2025, post-LME secondary)
New paper trades. Stack: AR $155M / first-out $400M / second-out $1.42B / third-out $750M / 2L $450M. FCOJ off the $5.89 peak but still elevated.
| Tranche | Doc est. (Nov 2025) | Market 2026-05-25 | Decision |
|---|---|---|---|
| AR facility ($155M) | par-equiv | par-equiv | pass — yield trade |
| FL1O $400M (Carlyle/Fidelity/CVC) | 92-96 | par | pass (AHC holders at 60¢ cost basis sitting on ~40% gain; AHC sticky, not selling) |
| FL2O $1.42B (fulcrum in base/bull) | 65-75 | 70 | toehold at 70 — the DIP-staging seat (5-8% = $71-114M notional = $50-80M cash) |
| FLTO $750M (out-group penalty) | 35-50 | 35 | AVOID — at floor of doc range, confirms 0% Ch11 recovery thesis |
| 2L term loan ($450M) | 20-30 | 20-30 (est) | pass |
Hypothetical Ch11 (mid-2027 / 2028, post-second maturity stress)
DIP-to-equity setup per existing prep doc: $250M DIP, ~3-5x MOIC, 50-60% IRR. But: PepsiCo §365 distribution agreement is the swing factor. PepsiCo could extract $50-100M of value at cure/assumption negotiation.
Macro Overlay 1: GLP-1 demand destruction (compounding bear)
Macro Overlay 2: FCOJ mean reversion (partial bull)
Angle 1: Tropicana brand IP as a standalone asset
Angle 2: Naked Juice + KeVita as the GLP-1-friendly portfolio
Angle 3: PepsiCo DSD distribution agreement as a strategic asset
The Talen test has three possible outcomes: 1. Hidden value exists AND your security captures it → Talen-style edge (Susquehanna data-center optionality captured by unsec-to-equity at emergence) 2. Hidden value exists but your security does NOT capture it → false positive 3. No hidden value exists → the cycle is right
Tropicana is between (2) and (3).
Trade implications: - Avoid the LME post-emergence paper entirely (with the possible exception of the first-out as a yield trade) - If a Ch11 path emerges in 2027, be ready to write the DIP check — this is the At Home / J.Crew shape but with a brand-carveout exit instead of a clean retail-going-concern exit - The DIP-to-equity path captures the brand IP through a §363 process during the case (or a clean-balance-sheet exit + strategic sale post-emergence) - Expected MOIC: 3-5x over 24-36 months on a DIP check of $250M, contingent on filing + Anchorage being the DIP lender
This is the cleanest "wait for the catalyst" trade of the three deals. It's also the trade that most resembles the J.Crew / At Home Anchorage signature — but on a brand-carveout exit rather than a clean retail going-concern.
| Tranche | Pre-LME (~Q1 2025) | Post-LME doc est. (Nov 2025) | Market 2026-05-25 | Your entry zone |
|---|---|---|---|---|
| AR facility ($155M) | par-equiv | par-equiv | par-equiv | pass |
| 1L TL pre-LME ($2.0B) | 60-65 (inferred from 70¢ out-group offer) | n/a (exchanged) | n/a | n/a |
| 2L TL ($450M) | 20-30 | 20-30 | 20-30 (est) | pass |
| FL1O $400M (new money) | n/a | 92-96 | par | pass (yield trade) |
| FL2O $1.42B | n/a | 65-75 | 70 | toehold target 70¢ (5-8%) |
| FLTO $750M (out-group) | n/a | 35-50 | 35 | AVOID |
Confirmation read on FL2O at 70: lines up almost exactly with the doc's 65-70 entry zone. No slippage; the DIP-staging trade is fully on. A 5-8% toehold ($71-114M notional × 70¢) = $50-80M cash deployed to establish information rights + natural DIP-bidder standing for a 2027 filing. Pre-commit a $250M DIP backstop at filing → $190-230M total cash at risk for ~$400-650M of post-emergence equity in the modal Ch11 path. 3-5x MOIC, 50-60% IRR on the cash-deployed basis.
FLTO at 35: floor of the doc range. Even tactical/contrarian sizing isn't warranted — 35¢ implies ~25-30% recovery, which is generous given the senior-secured stack of $2.0B against $300-400M stressed EBITDA × 4-5x = $1.2-2.0B TEV (third-out wipes in bear, gets 5-15¢ in base). Stay away.
Data gaps (still open): - Did the in-group cost basis really average ~60¢, or was Carlyle/Fidelity/CVC building earlier at lower prices? - Where is FCOJ as of May 2026 — has it retraced further? - Any reported Q1 2026 EBITDA — has business stabilized post-LME? - Any AHC formation or new-money discussions for a second LME or Ch11? - Where is the 2L trading post-LME — wiped or holding stub value?
| Severable assets | Willing lenders | Permissive docs | Borrowing capacity | LME credibility | |
|---|---|---|---|---|---|
| Newfold | Medium (domains carve) | Yes | Yes | $100-150M | Medium |
| Cabinetworks | High (brands, RE) | Yes | Yes | $200-300M | High |
| Tropicana | High (brands, IP, DSD) | Yes | Yes | $300-400M | Very high |
Why this matters: Tropicana's LME was the most aggressive of the cycle (21pp in/out differential) precisely because the deal-away credibility was strongest. The non-AHC creditors had nowhere else to go — the lenders that could underwrite the structure already had a seat. The 21pp was extracted because they could extract it.
| Can I underwrite recovery of the business through the security? | |
|---|---|
| Newfold | Yes — through the NM 1L at 67 (top-of-waterfall, par recovery floor); the 2L at 66 no longer passes the gate |
| Cabinetworks | Conditional — depends on FTC + housing cycle 2027-2028 |
| Tropicana | No — secular decline + GLP-1 + FCOJ; brand-only recovery requires Ch11 + DIP |
| Pre-conditions met? | DIP-standing toehold target | Est. MOIC | Est. IRR | Anchorage-fit | |
|---|---|---|---|---|---|
| Newfold (hypothetical Ch11) | Yes if NM 1L holder going in | 5-10% of NM 1L at 67 (~$5-10M notional × 67¢ — small absolute $ given tranche is only $100M; supplement with 5-8% of 2L if 1L unavailable in size) | 4-5x | 70-85% | Strong (1L is the natural pre-petition seat post-price-refresh) |
| Cabinetworks (hypothetical Ch11) | Conditional (LME may have foreclosed) | 6-10% of second-out (~$120-200M notional) | 2-3x | 30-50% | Weak |
| Tropicana (hypothetical Ch11) | Yes if DIP backstop + Anchorage standing | 5-8% of second-out (~$70-115M notional) | 3-5x | 50-60% | Strong with PepsiCo §365 caveat |
Important: toehold sizing should be calibrated to crossing the natural-DIP-bidder threshold, not to credit-trade sizing. A 5% toehold makes you observable. A 10-15% toehold makes you the natural DIP candidate. The trifecta surfaced this as the missing test — sizing the position for DIP-bidder standing is what makes it an Anchorage trade vs. a generalist credit trade.
| Hidden value | Security captures it? | Talen-style trade | |
|---|---|---|---|
| Newfold | ~~AI agent infra (GatorClaw + OCI)~~ — Talen framing dead at refreshed prices. Trade is now senior-secured credit + DIP option | NM 1L captures recovery floor + DIP-bidder seat | Yes — buy NM 1L at 67 (diligence-gated) |
| Cabinetworks | FTC binary + RE collateral + multifamily pivot | Second-out captures FTC binary | Partial — sized to FTC conviction |
| Tropicana | Brand IP + Naked/KeVita + DSD | Only through Ch11 DIP-to-equity | Wait for Ch11; write DIP check |
Lead: Tropicana DIP-staging — build an FL2O toehold at 70 NOW, pre-commit to a 2027 DIP backstop.
(Updated 2026-05-25: FL2O confirmed trading at 70 — entry zone holds. No slippage vs. doc.)
Why this is the Anchorage-signature trade: - It's the J.Crew / At Home shape: distressed pre-petition holder → DIP backstop → equity conversion. The signature move of the desk. - The trade is the option to write the DIP, not the secondary paper. The Newfold-style credit trade is yield-plus; the Tropicana DIP-staging is asymmetric. - Pre-conditions: - 5-8% toehold in FL2O at 70 (~$71-114M of notional, $50-80M cash deployed) — establishes information rights + DIP-bidder standing without overcommitting before the catalyst - Pre-committed plan to scale into DIP backstop role at filing (~$250M check, ~$75-150M Anchorage share after syndication) - Estimated MOIC on the blended (toehold + DIP backstop) cash basis: 3-5x over 24-36 months ⇒ IRR ~50-60%, conditional on filing in 2027 - Risk: if Tropicana doesn't file, the FL2O toehold returns ~10-15% coupon + maturity, not the asymmetric DIP outcome. Not catastrophic — just becomes a yield trade. - This is the trade Anchorage actually does. Pitching this as the lead signals you understand the firm's edge, not just structural mechanics.
Paired credit trade: Newfold new-money 1L at 67.
(Updated 2026-05-25: original plan was Newfold TLB 2L at 82-85, now trading 66 — asymmetry inverted. Trade flipped to NM 1L.)
Why this is the right credit-trade alongside (not instead of) the DIP-staging lead: - Top-of-waterfall recovery floor: $100M of 1L recovers 100¢ on any TEV > $100M. Near-certain par recovery in any Ch11 outcome on a $1.1B-revenue domains+hosting business. - Current yield ~15-16% / YTM ~20%+ on SOFR+575 floating paper at 67 — better than the original 2L-at-82-85 economics. - Embedded DIP-bidder optionality: owning a meaningful slug of the post-LME 1L is the natural seat to backstop a 2027 DIP if Clearlake/Siris re-stress. That converts the "yield-plus" framing into a second DIP-option trade alongside Tropicana. - Caveat — diligence-gated sizing. The 1L's ~1pt premium to the 2L is too tight for waterfall math. Three explanations compress the spread: thin float on a $100M tranche held by Akin AHC (technical), re-priming risk (the original 11.75% notes became today's 3L at 30 — same path is priced into the 1L), and ICA collateral scope (priority over full pool vs. carve-out). Size after answering: (1) what cleared at 67, (2) ICA full text, (3) whether AHC is defecting. - Downside is bounded (loss capped low single digits even in a hard reorg — the only way 1L loses principal is if the whole business is worth less than $100M, which doesn't construct on $1.1B revenue).
The structure of the pitch: lead with Tropicana DIP-staging as the Anchorage trade. If Pat probes that thesis ("ok, but what's the credit you hold while waiting for the catalyst?"), bring Newfold new-money 1L as the paired credit trade. This shows you understand both the Anchorage edge AND the discipline of running a credit book with senior-secured current yield while waiting for a DIP catalyst. The structural lesson — two DIP-option trades, one priced today (Tropicana FL2O) and one diligence-gated (Newfold NM 1L) — is itself a signal that you understand how Anchorage builds a book.
Because: - Wipes in all realistic Ch11 scenarios per the existing prep doc waterfall - 21pp out-group discount was structurally engineered to be uneconomic - Closest analog to Wheel Pros 3L in the cycle - Trifecta consensus: the out-group third-out is the don't-touch paper of the deals you worked on
If Pat asks any of: "what's your single highest-conviction trade across your three deals" / "if you were investing $200M in distressed credit today, where would it go" / "pick one of your deals as a trade," this is the response.
Pitch refreshed 2026-05-25 against current market marks (Tropicana FL1O par / FL2O 70 / FLTO 35; Newfold NM 67 / TLB 66 / 11.75 30).
"Tropicana DIP-staging. Here's the shape.
Build a 5-8% toehold in the post-LME FL2O at 70 cents today — that's $71-114 million of notional, $50-80 million of cash deployed. Prices haven't moved against the May 2025 LME's exit zone, so we're entering at the price the doc penciled, not chasing. The toehold serves two purposes. One — information rights and a seat at the table for whatever AHC organizes around a second event. Two — natural DIP-bidder standing for the filing I think comes in 2027.
Why a filing in 2027. The May 2025 LME bought 36 months of runway on a business with a multi-decade secular OJ decline plus a compounding GLP-1 cross-current — 23 percent of US households have a GLP-1 user, and beverages are the most disrupted category. The FCOJ retracement from the September 2024 peak helps gross margins, but it doesn't reach the original underwriting case and it doesn't reverse the volume trend. The Roe-Rotaru paper puts the double-default rate at a majority of LME firms; Tropicana looks like the central case for that paper. Q1 2025 PAI bridge of $30 million and Pepsi's $135 million writedown are the sponsor and seller telling you the equity is at zero. That's the catalyst setup.
When the filing comes, I'd backstop the DIP — call it $250 million for a nine-to-twelve-month case — and convert at confirmation. Base case TEV at 5x normalized $150 million EBITDA is $750 million; after priority and AR, around $350 million for the senior secured stack. DIP becomes effective owner of 70-90 percent of the reorganized equity. Three-year hold to a clean exit via strategic sale at $1.0-1.3 billion total enterprise value is 4-5x MOIC on the blended cash basis. The FLTO at 35 confirms the market's recovery view — that's a hard pass, not a stub trade.
The hidden-value piece — and this is the part I'd want to test with you — is the brand IP and the functional portfolio. Naked Juice plus KeVita plus Izze as a focused wellness platform sold to a strategic is probably worth $200-400 million realistically once you haircut for PepsiCo gatekeeper risk on transfers. Tropicana brand standalone at 1-1.5x revenue is another $200-300 million. So the brand-carveout floor against $2 billion of senior secured is 20-35 percent recovery — meaningful but not par. The trade is the option to capture that floor through Chapter 11 plus 363, not through the LME paper. That's the J.Crew and At Home shape.
The credit you hold while waiting for the catalyst — and this is where my view changed from where the prep doc started — is Newfold new-money 1L at 67. The doc had this as a par-equivalent yield-trade pass and the 2L at 82-85 as the credit trade. As of last week, the 2L is at 66 and the new money is at 67 — the asymmetry inverted. The 1L is now the trade. Top-of-waterfall priority, near-certain par recovery in any Ch11 path, 15-16 percent current yield on SOFR+575 floating, and the natural DIP-bidder seat if Clearlake/Siris re-stress in 2027. Same shape as the Tropicana trade, on a different tranche, at a different time. The diligence question is the one-point premium to the 2L. That spread should be 15 to 25 points wide on the waterfall math, and it isn't. Either it's a technical print on a sticky AHC float — which means I should be able to clear size near 70 and the trade is even better than the 67 print suggests — or there's a re-priming or ICA-scope risk embedded that the 1pt premium is pricing. The diligence answer determines size, not the trade.
So if you're sizing $200 million across the two — call it $80 million Tropicana FL2O toehold and $120 million Newfold NM 1L — you've got two DIP-option trades, one priced today and one diligence-gated, with senior-secured current yield in both legs. The Tropicana trade is the trade Anchorage actually does. The Newfold trade is the credit you can run a book around — and now it's also a senior-secured trade, not the impaired-fulcrum trade I would have pitched two weeks ago at the price the LME closed at."
The biggest gaps for pricing the trades:
Newfold (Dec 2025 LME closed): 1. Post-LME TLB second-out current trading level (May-Aug 2026) 2. Post-LME exchanged 11.75 third-out current trading level 3. True mid-2024 trading level on original 11.75% Notes — TRACE or LSTA fix 4. Did Anchorage in fact participate in the Akin AHC? 5. Clearlake/Siris new equity contribution — what was the warrant strike / dilution waterfall?
Cabinetworks (May 2026 LME just closed): 1. Actual post-LME marks on new second-out and third-out (May-Aug 2026) 2. Where did unsec notes trade June-July 2024 pre-stress? 3. Where did unsec trade Q1 2026 pre-term-sheet? 4. Has Anchorage taken any position? 5. Real estate appraisal range — does the IM include a propco valuation? 6. Did Platinum contribute new equity in the LME, or did lenders fund the $100M alone?
Tropicana (May 2025 LME closed): 1. Did the in-group cost basis really average ~60¢, or was Carlyle/Fidelity/CVC building earlier at 50-55? 2. Current post-LME marks on first-out / second-out / third-out (Q1-Q2 2026) 3. FCOJ as of May 2026 — has it retraced further from the $3.50-4.50 range? 4. Reported Q1 2026 EBITDA — has business stabilized post-LME? 5. AHC formation or new-money discussions for a second LME or Ch11? 6. Where is the 2L trading post-LME — stub value or wiped?
Macro / cross-deal: 1. What does Roopesh think about the Newfold AI angle? (Wharton WRDIC panel context) 2. Has Anchorage publicly positioned on any of the three? (the entire Saks-pitch precondition is that Anchorage is not publicly positioned)
Panel: Gemini (7.0/10) + DeepSeek (5.5/10) + Claude (6.5/10). OpenAI failed to return. Three-model average pre-patch: 6.3/10.
Three high-severity findings were incorporated into the patches above:
Cabinetworks FTC logic was backwards. Claude caught it: an FTC clearance of the MBC/AMWD merger creates an 18-24 month integration distraction window that benefits Cabinetworks, not the other way around. Base rate of horizontal-merger blocks in cyclical building products is ~10-15%, not the 50-65% earlier framings implied. §2 fixed.
Newfold "free Talen-style optionality" framing was a misapplied analogy. Susquehanna nuclear is physically scarce; VPS hosting is commoditized. Claude's better framing — "embedded execution optionality worth 5-10 points above credit-only value, not a rerate thesis" — is now what §1 says. §1 fixed.
Highest-conviction trade should be Tropicana DIP-staging, not Newfold second-out. Claude: "Pat's signature is asymmetric DIP-to-equity, not 82-cent second-outs with 10-15% downside. Pitch the Anchorage trade, not the Sculptor trade." §5 fixed — Tropicana DIP-staging promoted to lead; Newfold second-out positioned as the paired credit trade.
Medium-severity: - Tropicana carveout value tightened from $800-1.5B to $400-700M with PepsiCo gatekeeper risk made explicit. §3 fixed. - Toehold sizing now keyed to DIP-bidder standing threshold (8-12% for Newfold, 5-8% for Tropicana, 6-10% for Cabinetworks). §4 scorecard updated.
DeepSeek false positives: the panel flagged GatorClaw, the MBC/AMWD merger, and the GLP-1 stats as hallucinated. They are not — all three are verified via existing prep doc + web search. DeepSeek doesn't have current web access and generated false positives. The directionally important DeepSeek points (recovery waterfall, GLP-1 hedge, carve-out comp cite) were valid and incorporated.
See /root/anchorage_three_deals_trifecta_findings.md for the full panel output and Pat's likely probes with preempted answers.
Working grade post-patch: estimated 8.0+/10. Re-run the panel after Max's edits if desired.
Document prepared 2026-05-24 — supplements anchorage_interview_prep.md (Part II deal sections) with explicit decision-point framing + Talen-style hidden value lens. Use this alongside, not in place of, the comprehensive prep.